Raabta Pharma Private Limited

Raabta Pharma Private Limited - chemicals and materials in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24236TG2018PTC126275 Incorporated 23 August 2018 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company chemicals and materials MSME · Micro
Data last updated
Revenue · FY 2022
₹50.31 Lakh
▲ 75% YoY
Net loss · FY 2022
₹30.05 Lakh
Net margin -59.7%
EBITDA · FY 2022
-₹23.56 Lakh
EBITDA margin -46.8%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹40.25 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings

About Raabta Pharma Private Limited

Data last updated:

Raabta Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 23 August 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24236TG2018PTC126275. Its GSTIN is 36AAJCR0974L1ZV (Telangana). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Gudelli Supriya Patak and Pusati Bhaskar Reddy.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Flat No. 505 Vaishnavi Exotica Street No. 3 Kakatiya Nagar Habsiguda, Hyderabad, Telangana, India – 500007.

As per the financials filed for FY 2022, the company reported a revenue of ₹50.31 Lakh, a growth of 75% compared to the previous year. For the same year it recorded a net loss of ₹30.05 Lakh (net margin -59.7%) and EBITDA of -₹23.56 Lakh (EBITDA margin -46.8%).

As per MCA filings, the company has open charges of ₹40.25 Lakh on record.

Raabta Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0028886). For more details, the company can be reached via its website raabtapharma.com.

Company details

CIN U24236TG2018PTC126275
Registration Number 126275
Incorporation Date 23 August 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0028886

Recognitions & Rankings of Raabta Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-02-0028886

Contact details

Raabta Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is raabtapharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No. 505 Vaishnavi Exotica Street No. 3 Kakatiya Nagar Habsiguda, Hyderabad, Telangana, India – 500007
  • Industry
    Chemicals and Materials, Industrial Chemicals

To see the full contact details of Raabta Pharma Private Limited, buy the company report.

Comprehensive company report
Raabta Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Raabta Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Raabta Pharma Private Limited, buy the company report.

Financials of Raabta Pharma Private Limited

FY 2022 filings available

Raabta Pharma Private Limited reported revenue of ₹50.31 Lakh (up 75% YoY) for FY 2022.

Revenue · FY 2022
₹50.31 Lakh ▲ 75%
Net loss · FY 2022
₹30.05 Lakh margin -59.7%
EBITDA · FY 2022
-₹23.56 Lakh margin -46.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 75%
EBITDA CAGR growth
1 year
▼ 320%
3 years · compounded
▼ 318%

Revenue rose 75% in the latest year. EBITDA fell 320% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹23.56 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹30.05 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-46.8%
Net Profit Margin-59.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Raabta Pharma Private Limited, buy the company report.

Board of directors of Raabta Pharma Private Limited

Raabta Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gudelli Supriya PatakDirector23 Aug 20188 Years 2 MonthsCurrent
Pusati Bhaskar ReddyDirector23 Aug 20188 Years 2 MonthsCurrent

Auditor

Raabta Pharma Private Limited is audited by K Bhaskar & Associates for the financial year 2021.

Auditor firmFinancial yearFirm registration number
K Bhaskar & AssociatesFY 2021020817S

Shareholding

The shareholding of Raabta Pharma Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Raabta Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹40.25 Lakh
Satisfied charges
None
Breakdown by lending institutions
City Union Bank Limited₹0.40 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
10 Aug 2021100485138City Union Bank Limited₹40.25 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Raabta Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Raabta Pharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
36AAJCR0974L1ZVTelanganaActive01 Oct 2019
37AAJCR0974L1ZTAndhra PradeshActive08 Feb 2020

To see the full GST registrations and return filing status of Raabta Pharma Private Limited, buy the company report.

Recent activity

Raabta Pharma Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Surendra Babu Labbi ceased to be Director on 27 Nov 2019.

AGM
Raabta Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Raabta Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.
Charges
A charge with City Union Bank Limited amounted to Rs. 40.25 Lakh with Charge ID 100485138 was registered on 10 Aug 2021.
Ceased
Surendra Babu Labbi ceased to be Director.
Appointed
Gudelli Supriya Patak was appointed as Director.
Appointed
Pusati Bhaskar Reddy was appointed as Director.
Incorporation
23 Aug 2018
Raabta Pharma Private Limited was registered on 23 Aug 2018 with Roc Hyderabad & aged 8 years 2 months as per MCA records.

Frequently asked questions

Raabta Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 23 August 2018 (8+ years old) and is registered under CIN U24236TG2018PTC126275.

Raabta Pharma has 2 current directors:

The latest financial statements of Raabta Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Raabta Pharma is 36AAJCR0974L1ZV, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAJCR0974L1ZT (Andhra Pradesh).

The CIN (Corporate Identification Number) of Raabta Pharma is U24236TG2018PTC126275. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Raabta Pharma was incorporated on 23 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.

Surendra Babu Labbi ceased to be Director on 27 Nov 2019. Gudelli Supriya Patak was appointed as Director on 23 Aug 2018. Pusati Bhaskar Reddy was appointed as Director on 23 Aug 2018.

Yes, Raabta Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0028886).

Raabta Pharma can be reached through the website raabtapharma.com. Its registered office is in Hyderabad, Telangana, India.

The registered office of Raabta Pharma is at Flat No. 505 Vaishnavi Exotica Street No. 3 Kakatiya Nagar Habsiguda, Hyderabad, Telangana, India – 500007.